You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 The hydroxyproline values calculated in the different groups.

From: The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis

  Group 1 Group 2 Group 1 vs. Group 2
No SOM treatment Uninf.: 1.06 ± 0.10 Acute: 9.37 ± 0.63 p-value: 0.01** Chronic: 9.65 ± 0.96 Uninf.: 1.06 ± 0.10 Chronic: 9.65 ± 0.96 p-value: 0.007** Acute: 9.37 ± 0.63 Chronic: 9.65 ± 0.96 p-value: 0.90 (NS)
1 day SOM treatment Acute: 9.37 ± 1.24 Uninf.: 0.85 ± 0.08 Chronic: 8.99 ± 0.61 p-value: <0.0001** Acute: 9.37 ± 1.24 Chronic: 8.99 ± 0.61 p-value: 0.90 (NS)
2 day SOM treatment Uninf.: 0.81 ± 0.09 Acute: 4.76 ± 0.58 p-value: 0.007** Acute (untreated): 9.37 ± 0.63 Acute (2d SOM): 4.76 ± 0.58 p-value: 0.01** Uninf.: 0.93 ± 0.09 Chronic: 5.88 ± 1.13 p-value: 0.02* Chronic (untreated): 9.65 ± 0.96 Chronic (2d SOM): 5.8 ± 1.13 p-value: 0.03* Uninf. (17 wks.): 0.81 ± 0.09 Uninf. (21 wks.): 0.93 ± 0.09 p-value: 0.41 (NS) Acute: 4.76 ± 0.58 Chronic: 5.88 ± 1.13 p-value: 0.41 (NS)
  1. SOM: somatostatin; Uninf.: uninfected; Inf.: infected; Wks.: weeks;
  2. *Significant difference (p < 0.05); ** significant difference (p < 0.01);
  3. NS: not significant difference